Evidence map›Paper›PMID 33558767›Full record

ArticleActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2020

Results of a survey on elderly head and neck cancer patients on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Liliana Belgioia, Francesca De Felice, Almalina Bacigalupo, Daniela Alterio, Angela Argenone, Elisa D'Angelo, Isacco Desideri, Pier Francesco Franco, Anna Merlotti, Daniela Musio and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 1 country.

Liliana BelgioiaHealth Science Department (DISSAL), University of Genoa, Italy.
Francesca De FeliceDepartment of Radiotherapy, Policlinico Umberto I, "Sapienza" University of Rome , Italy.
Almalina BacigalupoRadiation Oncology Department, Policlinico San Martino Hospital, Genoa, Italy.
Daniela AlterioDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Angela ArgenoneRadiation Oncology Unit, A.O.R.N. San Pio Benevento, Italy.
Elisa D'AngeloRadiation Oncology Unit, University Hospital of Modena, Italy.
Isacco DesideriAzienda Ospedaliera Universitaria Careggi, Radiotherapy Unit, Oncology Department, University of Florence, Italy.
Pier Francesco FrancoDepartment of Oncology, Radiation Oncology, School of Medicine, University of Turin, Italy.
Anna MerlottiDepartment of Radiation Oncology, S. Croce and Carle Teaching Hospital, Cuneo, Italy.
Daniela MusioDepartment of Radiotherapy, Policlinico Umberto I, "Sapienza" University of Rome , Italy.
Ester OrlandiRadiotherapy 2 Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Stefano UrsinoDepartment of Radiation Oncology, University Hospital of Pisa, Italy.
Fabiola PaiarDepartment of Radiation Oncology, University Hospital of Pisa, Italy.
Azienda Ospedaliera Universitaria Pisana · ITOspedale Policlinico San Martino · ITAzienda Sanitaria Ospedaliera S.Croce e Carle Cuneo · ITEuropean Institute of Oncology · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITPoliclinico Umberto I · ITSapienza University of Rome · ITUniversity of Florence · ITUniversity of Modena and Reggio Emilia · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOver the years, evidence-based data and technical improvements have consolidated the central role of radiation therapy (RT) in head and neck cancer (HNC) treatment, even in the elderly. This survey aimed to describe the management of the elderly HNC patients among Italian Radiation Oncology Departments (RODs) and provide possible suggestions for improvement.

methodsAn online survey based on 43 questions was sent to RODs via email. For each RODs, a radiation oncologist with expertise in HNC was invited to answer questions addressing his/her demographic data, ROD multidisciplinary unit (MU) organisation and ROD management policy in elderly HNC patients.

resultsIn total, 68 RODs answered, representing centres located in 16 Italian regions. MU was considered the core of HNC patient management in almost all the entire country. However, in many RODs, there was minimal access to a routinely comprehensive geriatric assessment at diagnosis. Most treatments were reported by respondents as curative (89% on average) and the preferred treatment technique was intensity modulated radiation therapy (IMRT). A considerable variation between RODs was found for RT target volumes. There was a relation between the specialist's years of experience and type of concomitant systemic therapy prescribed.

conclusionsSubstantial differences in elderly HNC management have been found, especially concerning patient clinical evaluation and target volume delineation. This survey shows the necessity to design a prospective national trial to provide a uniform treatment strategy and define an effective patient-centred approach.

Indexed as

Head and Neck NeoplasmsRadiation OncologyRadiotherapy, Intensity-ModulatedAgedFemaleHumansItalyMaleMedical OncologyProspective StudiesSurveys and Questionnairescombined treatmentelderly patientshead and neck cancerradiotherapy

Identifiers

PMID33558767
PMCPMC7889254
OpenAlexW3127182278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.